Event Hero





Visit Karius at Next Generation Dx Summit 2018

At Karius, we are focused on helping clinicians diagnose infections, guide treatment, and ultimately improve care for all patients.

The Karius® Test is a comprehensive genomic assay that can identify more than 1,000 pathogens from a standard blood draw, including bacteria, DNA viruses, fungi, molds and protozoa. It uses next-generation sequencing to detect cell-free pathogen DNA circulating in a patient’s bloodstream.

At Next Generation Dx Summit 2018, Karius Co-Founder and Chief Scientific Officer Dr. Tim Blauwkamp will speak about "Analytical and Clinical Validation of a Microbial Cell-Free DNA Assay for Pathogen Detection".

Next Generation Dx Summit, August 20-24, 2018
Karius Presentation Schedule

Karius will be exhibiting at Booth #109


Analytical and Clinical Validation of a Microbial Cell-Free DNA Assay for Pathogen Detection
C1B: Molecular Diagnostics for Infectious Disease track

LUNCHEON Presentation: Wednesday, August 22, 2018 at 12:45 pm

Presentation Summary:

Microbial cell-free DNA sequencing offers great potential to noninvasively identify a wide range of pathogens, but a number of challenges associated with such comprehensive testing must be addressed. We share our experience developing and validating a next-generation sequencing test that identifies and quantifies microbial cfDNA in plasma from 1,250 clinically relevant pathogens. Particular attention will be paid to the novel strategies and experiments that we employed to characterize performance across a broad range of pathogens throughout the analytical and clinical validation studies.

To learn more about the Karius Test and how it can help your patients, please drop by booth #109 or email info@kariusdx.com to schedule time with members of our team who can share recent clinical data and cases where the Karius Test was used to help patients.

We look forward to meeting you.

Meet Karius at Next Generation Dx Summit
August 20-24, 2018
Washington, DC
Booth #109